These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37949473)

  • 21. Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
    Li W; Tu J; Liu X; Yang W
    Clin Exp Immunol; 2017 Oct; 190(1):8-18. PubMed ID: 28556912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated Ovarian Cancer Cells Stably Transfected with Bcl3 shRNA.
    Padmanabhan S; Zou Y; Vancurova I
    Methods Mol Biol; 2020; 2108():211-220. PubMed ID: 31939183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells.
    Hua S; Gu M; Wang Y; Ban D; Ji H
    Clin Transl Oncol; 2021 Apr; 23(4):750-756. PubMed ID: 32737836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the PD-1/PD-L1 axis in macrophage differentiation and function during pregnancy.
    Zhang Y; Ma L; Hu X; Ji J; Mor G; Liao A
    Hum Reprod; 2019 Jan; 34(1):25-36. PubMed ID: 30500923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice.
    Tsuruta A; Shiiba Y; Matsunaga N; Fujimoto M; Yoshida Y; Koyanagi S; Ohdo S
    Mol Cancer Res; 2022 Jun; 20(6):972-982. PubMed ID: 35190830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non-Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab.
    Higgs BW; Morehouse CA; Streicher K; Brohawn PZ; Pilataxi F; Gupta A; Ranade K
    Clin Cancer Res; 2018 Aug; 24(16):3857-3866. PubMed ID: 29716923
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice.
    Dimitrov V; Bouttier M; Boukhaled G; Salehi-Tabar R; Avramescu RG; Memari B; Hasaj B; Lukacs GL; Krawczyk CM; White JH
    J Biol Chem; 2017 Dec; 292(50):20657-20668. PubMed ID: 29061851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decidual macrophages derived NO downregulates PD-L1 in trophoblasts leading to decreased Treg cells in recurrent miscarriage.
    Zhang Y; Wang H; Qiu P; Jiang J; Wu X; Mei J; Sun H
    Front Immunol; 2023; 14():1180154. PubMed ID: 37520550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune regulation of canine tumour and macrophage PD-L1 expression.
    Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
    Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostasin regulates PD-L1 expression in human lung cancer cells.
    Chen LM; Chai JC; Liu B; Strutt TM; McKinstry KK; Chai KX
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34240739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling.
    Zong Z; Zou J; Mao R; Ma C; Li N; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Front Immunol; 2019; 10():1643. PubMed ID: 31379842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of PD-L1 Expression by NF-κB in Cancer.
    Antonangeli F; Natalini A; Garassino MC; Sica A; Santoni A; Di Rosa F
    Front Immunol; 2020; 11():584626. PubMed ID: 33324403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas.
    Jeon S; Rowe AM; Carroll KL; Harvey SAK; Hendricks RL
    J Immunol; 2018 Jun; 200(11):3711-3719. PubMed ID: 29669784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation.
    Hartley GP; Chow L; Ammons DT; Wheat WH; Dow SW
    Cancer Immunol Res; 2018 Oct; 6(10):1260-1273. PubMed ID: 30012633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic Amplification of
    George J; Saito M; Tsuta K; Iwakawa R; Shiraishi K; Scheel AH; Uchida S; Watanabe SI; Nishikawa R; Noguchi M; Peifer M; Jang SJ; Petersen I; Büttner R; Harris CC; Yokota J; Thomas RK; Kohno T
    Clin Cancer Res; 2017 Mar; 23(5):1220-1226. PubMed ID: 27620277
    [No Abstract]   [Full Text] [Related]  

  • 37. Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma.
    Kong SK; Kim BS; Lim H; Kim HJ; Kim YS
    Lab Invest; 2022 Apr; 102(4):352-362. PubMed ID: 34789838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells.
    Yee D; Shah KM; Coles MC; Sharp TV; Lagos D
    J Biol Chem; 2017 Dec; 292(50):20683-20693. PubMed ID: 29066622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow Cytometry Analysis of Surface PD-L1 Expression Induced by IFNγ and Romidepsin in Ovarian Cancer Cells.
    Padmanabhan S; Zou Y; Vancurova I
    Methods Mol Biol; 2020; 2108():221-228. PubMed ID: 31939184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1.
    Roux C; Jafari SM; Shinde R; Duncan G; Cescon DW; Silvester J; Chu MF; Hodgson K; Berger T; Wakeham A; Palomero L; Garcia-Valero M; Pujana MA; Mak TW; McGaha TL; Cappello P; Gorrini C
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4326-4335. PubMed ID: 30770442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.